GALT 241220 2.50P (GALT241220P2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

GALT241220P2500

Watchlist

1.45
+0.85+141.67%

15min DelayClose Dec 20 16:00 ET

1.78High1.00Low

Intraday

5D
Daily

News

Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients With Cirrhotic Portal Hypertension Caused by MASH
GlobeNewswireDec 20 08:00 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga16:06 ET
Catalyst Watch: Labor Pains for Amazon & Starbucks, Nasdaq Call-up for MicroStrategy and Pony AI Ratings
Seeking Alpha15:00 ET
Galectin Therapeutics Shares Drop 54% After Treatment Misses Trial Endpoint
WSJ14:44 ET
Top Midday Decliners
MT Newswires14:16 ET
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
Benzinga13:05 ET

Comments

SkinnyChick

16 hours ago

$Galectin Therapeutics (GALT.US)$ same story with SAVA, 101% the company gone case

Jaguar8

Dec 15 20:58

🔶December 2024 Upcoming Catalysts. Save it. In alphabetical order

$ABVC BioPharma (ABVC.US)$ - Progress continues in our ADHD program with Phase IIb trials at multiple prominent sites. We aim to have an interim report by Q4 2024. ABV-1601 for MDD in cancer patients has completed Phase I study preparation, including the Site Initiation Visit (SIV). The study is set to initiate by the end of 2024.
$Ascent Solar Technologies (ASTI.US)$- Following delivery and the successful completion of the on-orbi...

GreenIsMyName

Oct 3, 2023 07:01

$Galectin Therapeutics (GALT.US)$ news about outcome of fourth data and safety

Mcsnacks H Tupack

Mar 5, 2023 01:40

Last resistance

$Galectin Therapeutics (GALT.US)$ Breakout is at 2.57. That should run it to 4.80 after shorts cover.

ilovemoney29

Nov 2, 2022 20:15

$Galectin Therapeutics (GALT.US)$ going to have presentations from 4 to 8 nov, where they share scientific sharings. will be watching this